Parexel, Catalent partner for clinical trial material supply management

The alliance will offer integrated services and technologies across the entire clinical trial material supply chain spectrum to support all supply aspects in clinical development programs.

Catalent clinical supply services chief operating officer, vice president and general manager Gerry Hepburn said, "PAREXEL, with its extensive and unparalleled track record in clinical development, is the ideal partner for Catalent in this alliance, which will enable our customers to compete more effectively in the global marketplace."

The main services of the alliance include planning and development of supply strategies, central and local clinical trial and ancillary material sourcing, global and local storage as well as distribution to trial sites, depot, site and patient inventory management, material return and destruction/disposition and so on.

Parexel clinical logistics services corporate vice president Kurt Norris said, "One of the most important steps in creating a strong, efficient clinical trial material supply chain is selecting a partner with innovative clinical packaging solutions and established global operations to oversee and coordinate all aspects of each critical supply chain stage."

The alliance will offer integrated services and technologies across the entire clinical trial material supply chain spectrum to support all supply aspects in clinical development programs.

The main services of the alliance include planning and development of supply strategies, central and local clinical trial and ancillary material sourcing, global and local storage as well as distribution to trial sites, depot, site and patient inventory management, material return and destruction/disposition and so on.

The alliance is the result of Catalent’s February 2012 acquisition of the clinical trial supplies business of Aptuit.